BeOne Medicines AG

OTCPK:BEIG.F Stock Report

Market Cap: US$30.1b

BeOne Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:BEIG.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 May 26SellUS$65,424Michael GollerIndividual2,743US$23.85
22 May 26SellUS$65,567Ranjeev KrishanaIndividual2,756US$23.79
07 May 26BuyUS$9,850,618JPMorgan Chase & Co.Company406,077US$24.26
05 May 26SellUS$15,875,801JPMorgan Chase & Co.Company706,527US$22.47
03 Feb 26BuyUS$27,382,569JPMorgan Chase & Co.Company1,043,793US$26.23
16 Jan 26BuyUS$746,288JPMorgan Chase & Co.Company28,691US$26.01
16 Jan 26SellUS$3,043JPMorgan Chase & Co.Company117US$26.01
16 Jan 26SellUS$43,529,376JPMorgan Chase & Co.Company1,673,484US$26.01
15 Jan 26BuyUS$938,717JPMorgan Chase & Co.Company35,574US$26.39
15 Jan 26BuyUS$40,931,728JPMorgan Chase & Co.Company1,551,166US$26.39
15 Jan 26SellUS$5,048,683JPMorgan Chase & Co.Company191,327US$26.39
14 Jan 26BuyUS$245,091JPMorgan Chase & Co.Company9,254US$26.48
14 Jan 26BuyUS$4,445,648JPMorgan Chase & Co.Company167,856US$26.48
14 Jan 26SellUS$103,291JP Morgan Asset ManagementCompany3,900US$26.48
14 Jan 26SellUS$129,458JPMorgan Chase & Co.Company4,888US$26.48
14 Jan 26SellUS$51,296,731JPMorgan Chase & Co.Company1,936,830US$26.48
12 Jun 25BuyUS$1,944JP Morgan Asset ManagementCompany91US$21.37
12 Jun 25BuyUS$13,332JPMorgan Chase & Co.Company624US$21.37
12 Jun 25BuyUS$23,747,222JPMorgan Chase & Co.Company1,111,477US$21.37
12 Jun 25SellUS$79,159JPMorgan Chase & Co.Company3,705US$21.37

Insider Trading Volume

Insider Buying: BEIG.F insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of BEIG.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies379,5010.341%
Individual Insiders4,925,1894.43%
Hedge Funds8,881,7167.99%
Public Companies18,938,11917%
General Public21,655,67619.5%
Institutions56,360,47350.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.96% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17%
Amgen Inc.
18,938,119US$5.1b0%no data
7.99%
Baker Bros. Advisors LP
8,881,716US$2.4b0.94%13.07%
6.44%
Capital Research and Management Company
7,158,809US$1.9b12.2%0.07%
4.74%
Hillhouse Investment Management, Ltd.
5,271,893US$1.4b0%6.76%
4.48%
PRIMECAP Management Company
4,975,181US$1.3b-0.11%0.82%
3.47%
John Oyler
3,858,922US$1.0b0%no data
3.3%
FMR LLC
3,670,557US$994.3m-7.46%0.04%
2.96%
BlackRock, Inc.
3,285,842US$890.1m-2.66%0.01%
2.67%
China Asset Management Co. Ltd.
2,965,378US$803.3m0.28%0.67%
1.86%
Vanguard Capital Management, LLC
2,061,786US$558.5m0.2%0.01%
1.07%
Norges Bank Investment Management
1,191,543US$322.8m0%0.02%
0.97%
T. Rowe Price Group, Inc.
1,079,743US$292.5m-45.6%0.02%
0.93%
Citadel Advisors LLC
1,032,298US$279.6m93.5%0.18%
0.89%
ICBC Credit Suisse Fund Management Co., Ltd
989,361US$268.0m0%0.97%
0.79%
China Universal Asset Management Company Ltd.
880,090US$238.4m0.06%0.64%
0.78%
Temasek Holdings (Private) Limited
862,643US$233.7m-6.19%0.14%
0.64%
Xiaodong Wang
716,430US$194.1m0%no data
0.6%
Zhong Ou Fund Management Co., Ltd
663,936US$179.8m0%0.81%
0.56%
Baillie Gifford & Co.
621,810US$168.4m-3.99%0.08%
0.53%
UBS Asset Management AG
591,121US$160.1m80.7%0.01%
0.5%
Bosera Asset Management Co., Ltd.
555,119US$150.4m0%0.59%
0.48%
Vanguard Fiduciary Trust Company
527,978US$143.0m0.45%0.02%
0.47%
Fullgoal Fund Management Co. Ltd.
521,298US$141.2m0%0.33%
0.42%
Artal Group S.A.
465,000US$126.0m-7%2.41%
0.39%
CSOP Asset Management Limited
430,880US$116.7m5.94%0.73%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/09 10:09
End of Day Share Price 2026/06/09 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BeOne Medicines AG is covered by 68 analysts. 34 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tianli WenAletheia Analyst Network Limited
Brian SkorneyBaird
Peter LawsonBarclays